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Problem Identification
• There is a global lack of research, recognition, diagnosis, and
treatment of atherosclerotic cardiovascular disease (ASCVD) in
women1
• ASCVD is traditionally considered a “male disease”, yet it is the leading
cause of mortality in women (35% of total deaths in women in 2019)1,
• Historical female exclusion/underrepresentation in ASCVD clinical trials
has hindered accurate measurement of therapy safety/efficacy in
women and development of accurate guidelines for primary ASCVD
prevention1

https://www.heart.org/-/media/Files/About-Us/Policy-Research/Fact-Sheets/Public-Health-Advocacy-andResearch/Projections-of-CVD-Prevalence-and-Costs-2015-2035.pdf

• Despite an increase in ASCVD awareness in women over the past 20
years, common sex-specific obstacles to prevention persist2, and only
~40% of physicians feel well-prepared to assess and manage CVD
risk in women3
• Current evidence demonstrates a sex-specific lower likelihood,
especially in younger women, of receiving guideline-recommended
CVD therapies4
Likelihood (odds ratio) of receiving evidence-based
treatment, categorized by gender and age category5

Problem Identification, cont.
• The prevalence of
ASCVD in Vermont
(8%) is comparable to
that of the U.S. (9%)6
• Approx. 1.1% of
hospital discharges in
2015 were due to
primary diagnosis of
ASCVD, compared to
4.3% due to any
mention of ASCVD as a
contributing factor6

Public Health Cost
• ASCVD is projected to impact 45.1%
of the U.S. population by 20355
• Total direct medical cost of ASCVD is
projected to double from 2015 to
2035, reaching an est. $749 billion5

Projected total costs of CVD, 2015 to 2035 (2015 dollars in billions) in the
United States. CHD indicates coronary heart disease; CHF, congestive heart
failure; CVD, cardiovascular disease; and HBP, high blood pressure.

• 55% of projected direct medical costs
of ASCVD will be attributable to
hospitalization expenses5
Projected direct costs of total cardiovascular disease by type of cost from
2015 to 2035 (2015 dollars in billions).

One American Heart Association study
determined that 95% of women report
prodromal symptoms >1 month before acute
myocardial infarction (AMI)7
• Includes: Unusual fatigue (70%), sleep disturbance (47%),
shortness of breath (42%)
• Only 30% reported prodromal chest discomfort
• Acute chest pain was absent in 43%

How can earlier detection of ASCVD
risk in women reduce missed signs
of AMI/Stroke and thereby lower the
economic burden of preventable
ASCVD hospitalizations?
Risk factors for cardiovascular disease in women1

Community Perspective
“I recall a female patient with several
months of exertional jaw pain for prior to a
myocardial infarction. This was not
recognized as potential cardiac pain by
either the patient or primary care provider.
If so, early intervention (i.e. stress test or
catheterization) may have spared her that
event.”
Recognizing symptoms of ischemia is most
important – It does not have to be the
classic substernal chest pressure. Also,
recognizing that women are susceptible to
coronary artery dissections where the
classic risk factors (smoking, diabetes,
older age) do not necessarily apply. "

Dr. Lauren Suggs,
Cardiologist, UVMMC

"What I do see, though, is a lingering
lack of awareness on the part of
women that they may be at risk, or
that their symptoms could be a heart
attack, and this can lead to delays in
care.
Another component is that women
patients are more likely to be
concerned about their family duties
and sometimes delay care because
of that, or because they themselves
lack awareness that they could be at
risk."

Dr. Friederike Keating,
Cardiologist, UVMMC

“The ‘You First’ program is part of the CDC’s
national WISE WOMEN initiative that focuses
heavily on cardiovascular disease prevention
in folks aged 30-64. We conduct initial heart
health screens and can then offer services in
nutrition, physical activity, and smoking
cessation. For those without insurance
coverage, we can help pay for transportation
and clinical services.
Many patients first contact us about blood
pressure, whether they’ve just seen their
primary care provider or had just been to
the emergency room, because they’re
scared for their health. They finally got to a
point in their life where they really want to
find support and make healthy behavior
changes."

Siobhan Donegan,
Vermont Dept. of Health

Community Perspective, cont.
What role can primary care physicians play to address barriers in earlier recognition,
prevention, and management of ASCVD in women?
“Outreach should focus on educating patients on the wide
array of symptoms and to never be afraid to bring things
up with their cardiologists or primary care physicians. It's
our jobs to parse through what is relevant or not – they
should never hesitate to let us know.”

Dr. Lauren Suggs,
Cardiologist, UVMMC

"There are plenty of opportunities to collaborate with
physicians, since they are the main source of patient
referrals to the program. Although a local physician may
see, at most, 20 total You First member visits per year,
membership is growing, and we wish more providers
knew about us.”

"PCPs meet many women long before there are any events. They are the
first to address risk factors, in many cases, and the first to discuss
prevention. CVD risk assessment and prevention is one of the most
holistic encounters one can have with a patient. Outreach involves going
to places where women are and talking to them about CVD That could be
in their workplace, during work events, through their health insurance, in
library talks, even at the gym."

Dr. Friederike Keating,
Cardiologist, UVMMC

Siobhan Donegan,
Vermont Dept. of Health

Intervention & Methodology
• Patient Education & Social Determinants of Health
• I designed an informational handout for patients that was made available for
distribution in the Colchester Family Medicine waiting room and MyChart.
• Includes ASCVD basics, statins risks & benefits, topics to discuss with primary care
provider, links to local & national heart health organizations

• Interprofessional Education
• I developed an EPIC smartphrase for providers to reference as a guide for
assessing sex-specific ASCVD risk factors and inform patient-centered
discussion of lifestyle changes and preventative therapies.

Result

SmartLists

Result cont.

Sx: fatigue, dyspnea, chest pain, chest
pressure, palpitations, shoulder pain, jaw
pain, back pain, radiation to arm, cough,
nausea/vomiting, indigestion, dizziness,
numbness
Freq: First episode, constant, intermittent,
regular, irregular, daily, several
days/week, several days/month, few
times/year, frequency stable, frequency
increasing
Comorbid: Hypertension, hyperlipidemia,
diabetes, hypo/hyperthyroidism, obesity,
anxiety/panic disorder, current tobacco
use, former tobacco use, illicit drug use
Menopause: pre-, peri-, post-menopausal,
on estrogen replacement therapy, on
combined OCPs
Stressors: Work, home, family,
relationships, finances, other
Other: pleuritic, positional, reproduced by
palpation

Evaluation of Effectiveness & Limitations
ASCVD Patient Handout

Smartphrase for Family Physicians

• Effectiveness is quantitatively measured by
the number of pamphlets taken by patients
from high-traffic areas of the clinic,
including the exam and waiting rooms, and
the number distributed online via MyChart.

• Effectiveness is qualitatively assessed
based on physicians’ personal feedback
regarding frequency of use, efficiency, and
thoroughness.

• Limitations of this medium of patient
education are mainly associated with
patient interest, motivation, literacy level,
and non-English native language.

• Limitations of this medium of physician
practice transformation are related to time
constraints for physicians to integrate new
risk assessments and sustaining general
awareness of when and how to apply this
resource into their notes.

Recommendations for Future Interventions
• Continue incorporating recurrent interprofessional education of family medicine
physicians and nurses to better recognize atypical symptoms of female ASCVD
presentation.
• Encourage physicians to use HerHeart smartphrases and project handout when
applicable, and to follow up with patients about relevant resource information.
• Generate EMR reports of Colchester Family Medicine the number of female patient
hospitalizations due to acute MI/stroke pre- and post-intervention and whether they
were prescribed appropriate preventative therapy.
• Form a multidisciplinary team to connect PCPs with cardiologists, nutritionists, and
public health officials to maintain and expand project efforts.
• Continue fostering collaboration between PCPs and You First program representatives
to support 30-64 year-old women with ASCVD risk and financial limitations.
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Interview Consent Form
• Thank you for agreeing to be interviewed. This project is a requirement for the Family Medicine
clerkship. It will be stored on the Dana Library ScholarWorks website. Your name will be attached
to your interview and you may be cited directly or indirectly in subsequent unpublished or
published work. The interviewer affirms that he/she has explained the nature and purpose of this
project. The interviewee affirms that he/she has consented to this interview.
• Consented
• Name: Siobhan Donegan
• Name: Lauren Suggs
• Name: Friederike Keating

